An open label single arm clinical study on the combined effectiveness of Chitrakadi Vati and Avipathi Churnam in the management of Hypothyroidism

Dr Anoop A S0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Diagnosis will be made on the basis of TSH value more than 15-20 mU/l which may or may not be associated with decrease in T3 and T4 concentration and also with the signs and symptoms of Hypothyroidism one or multiplicity of these viz
•1.tiredness,
•2.dryness of skin,
•3.feeling cold
•4.hair loss,
•5.constipation,
•6.Weight gain with poor appetite
•7.Hoarseness of voice,
•8.muscle ache or stiffness,
•9.menstrual disturbances,
•10.Bradycardia
•11.periorbital puffiness.
•Inclusion criteria include
•1.Patients of age between 18 to 60 years of either gender
•2.Patients already diagnosed as hypothyroidism with or without medication,
•3.Patients with Primary hypothyroidism,
•4.Patients with subclinical hypothyroidism,
•5.Patients who are ready to sign the informed consent form

•Exclusion criteria are as follows
•1.Patients who have undergone any type of thyroid surgery,
•2.Patients suffering from systemic diseases like Ischemic Heart Disease, Diabetes mellitus, carcinomas,
•3.Patients suffering from congenital hypothyroidism,
•4.Pregnancy and lactation,
•5.Rapid progressive case of myxedema,
•6.Hypothyroidism due to drug therapy (e.g. Amiodarone, Lithium, Interferon)
•7.Hypothyroidism due to infiltrative diseases like Sarcoidosis,Scleroderma and Haemochromatosis

发起方

Dr Anoop A S